Skip to main content

Table 2 Genotype counts and allele frequencies of ADIPOR2 SNPs in the DPS and Genobin study population

From: Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study

SNP and its location within gene

     

HWE

 

Population

Genotype counts

MAF

p/qa

p/qb

rs10848554

 

GG

GC

CC

C

  

5' promoter region

DPS

373

104

7

0.122

0.934/0.389

0.401/0.204

 

Genobin

44

12

0

0.107

0.369/0.377

 

rs11061937

 

TT

TC

CC

C

  

Intron 1

DPS

213

214

57

0.339

0.772/0.378

0.208/0.170

 

Genobin

16

27

13

0.473

0.805/0.378

 

rs11061946

 

CC

CT

TT

T

  

Intron 1

DPS

430

49

5

0.061

0.011/0.377

0.042/0.170

 

Genobin

48

8

0

0.071

0.565/0.377

 

rs1058322

 

CC

CT

TT

T

  

Intron 1

DPS

230

206

48

0.320

0.850/0.378

0.958/0.299

 

Genobin

22

29

5

0.348

0.292/0.377

 

rs11061973

 

GG

GA

AA

A

  

Intron 2

DPS

403

76

5

0.089

0.508/0.377

0.027/0.170

 

Genobin

44

12

0

0.107

0.369/0.377

 

rs4766415

 

AA

AT

TT

T

  

Intron 2

DPS

128

254

102

0.473

0.247/0.377

0.243/0.170

 

Genobin

11

26

19

0.429

0.697/0.378

 

rs16928751

 

GG

GA

AA

A

  

Exon 7

DPS

379

101

4

0.113

0.331/0.377

0.493/0.206

 

Genobin

47

9

0

0.080

0.513/0.377

 

rs1044471

 

CC

CT

TT

T

  

3' UTR

DPS

136

245

103

0.466

0.706/0.378

0.578/0.207

 

Genobin

22

28

6

0.357

0.506/0.377

 
  1. ap/q value for Hardy-Weinberg equilibrium; bp/q value for differences in genotype frequencies between the study groups of DPS; Correction for multiple hypothesis testing was performed with FDR, denoted as q-value.